Sfoglia per Autore
Lung adenocarcinoma. Molecular-Based Decision Making for Personalized Cancer Management
2012-01-01 R., Rosell; M. L., Botero; T., Bivona; P., Mendez; A. F., Cardona; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascó; C., Buges; T., Moran; Santarpia, Mariacarmela; M. A., Molina; L., Romero; F., Salazar; J. L., Ramirez; C., Queralt; J., Bertran Alamillo; I., Chaib; C., Costa; S., Benlloch; A., Vergnenegre; P., Garrido; C., Camps; M., Provencio; J. M., Sanchez; J., de Castro; B., Massuti
Triple-negative breast cancer
2012-01-01 R., Rosell; M. L., Botero; M., Gonzales Cao; M., Margeli; A., Barnadas; M. T., Cusido; R., Fabregas; C., Costa; A., Gimenéz Capitan; Santarpia, Mariacarmela; S., Benlloch
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
2013-01-01 Fabio, Conforti; Chiara, Catania; Francesca, Toffalorio; Matteo, Duca; Gianluca, Spitaleri; Massimo, Barberis; Cristina, Noberasco; Angelo, Delmonte; Santarpia, Mariacarmela; Chiara, Lazzari; Tommaso Martino De, Pas
Cost-utility analysis of first-line treatment with erlotinib versus chemotherapy in EGFR-mutant advanced non-small-cell lung cancer (NSCLC): economic analysis of EURTAC trial (O16.03)
2013-01-01 Vergnenegre, Alain; Rosell, Rafael; Massuti, Bartomeu; Do, Pascal; Corre, Romain; Felip, Enriqueta; Palmero, Ramon; Garcia Gomez, Ramon; Marinis, Filippo De; Santarpia, Mariacarmela; Wright, Elaine; Chouaid, Christos
Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients.
2013-01-01 Santarpia, Mariacarmela; De Pas, T. M.; Altavilla, Giuseppe; Spaggiari, L.; Rosell, R.
Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets
2014-01-01 F. Toffalorio;G. Spitaleri;C. Catania;L. Dal Zotto;C. Noberasco;A. Delmonte;M. Santarpia;F. Vecchio;V. Brunelli;C. Rampinelli;M. Barberis;C. Fumagalli;M. Zucchetti;M. Zangarini;T. Diena;R. Danesi;F. de Braud;T. De Pas
Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options
2014-01-01 Chiara Lazzari;Gianluca Spitaleri;Chiara Catania;Massimo Barberis;Cristina Noberasco;Mariacarmela Santarpia;Angelo Delmonte;Francesca Toffalorio;Fabio Conforti;Tommaso Martino De Pas
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013
2015-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ien6le, Valen6na; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebas6ano Pollina; Scondo_o, Salvatore; Cananzi, Pasquale; Caputi Achille, Patrizio; Trifiro', Gianluca
Other targeted drugs in melanoma
2015-01-01 González Cao, María; Rodón, Jordi; Karachaliou, Niki; Sánchez, Jesús; Santarpia, Mariacarmela; Viteri, Santiago; Pilotto, Sara; Teixidó, Cristina; Riso, Aldo; Rosell, Rafael
Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
2015-01-01 Karachaliou, Niki; Cao, Maria Gonzalez; Teixidó, Cristina; Viteri, Santiago; Morales Espinosa, Daniela; Santarpia, Mariacarmela; Rosell, Rafael
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013
2015-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ientile, Valentina; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebastiano Pollina; Scondotto, Salvatore; Cananzi, Pasquale; Caputi, Achille Patrizio; Trifirò, Gianluca
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: Understanding transforming growth factor-beta role
2015-01-01 Santarpia, Mariacarmela; González Cao, María; Viteri, Santiago; Karachaliou, Niki; Altavilla, Giuseppe; Rosell, Rafael
Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
2015-01-01 Santarpia, Mariacarmela; Gil, Nuno; Rosell, Rafael
Polycythemia vera and essential thrombocytemia treated with IFN-ALPHA2a: Evidence of a significant clinical activity and molecular response.
2015-01-01 Altavilla, Giuseppe; Arrigo, C; Santarpia, Mariacarmela; Garipoli, Claudia; Pitini, V. (Pitini
Advances in immunotherapy for treatment of lung cancer
2015-01-01 Bustamante Alvarez, Jean G; González Cao, María; Karachaliou, Niki; Santarpia, Mariacarmela; Viteri, Santiago; Teixidó, Cristina; Rosell, Rafael
Melanoma: oncogenic drivers and the immune system
2015-01-01 Karachaliou, Niki; Pilotto, Sara; Teixidó, Cristina; Viteri, Santiago; González Cao, María; Riso, Aldo; Morales Espinosa, Daniela; Molina, Miguel Angel; Chaib, Imane; Santarpia, Mariacarmela; Richardet, Eduardo; Bria, Emilio; Rosell, Rafael
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
2015-01-01 Karachaliou, Niki; Codony Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony Servat, Carles; Giménez Capitán, Ana; Molina Vila, Miguel Angel; Bertrán Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García Campelo, Rosario; Viteri, Santiago; González Cao, María; Morales Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch Barrera, Joaquim; Felipe Cardona, Andrés; De Marinis, Filippo; López Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael
Tumor immune microenvironment characterization and response to anti-PD-1 therapy
2015-01-01 Santarpia, Mariacarmela; Karachaliou, Niki
Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
2015-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Rosell, Rafael
Personalized treatment of early-stage non-small-cell lung cancer: The challenging role of EGFR inhibitors
2015-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Pitini, Vincenzo; Rosell, Rafael
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lung adenocarcinoma. Molecular-Based Decision Making for Personalized Cancer Management | 1-gen-2012 | R., Rosell; M. L., Botero; T., Bivona; P., Mendez; A. F., Cardona; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascó; C., Buges; T., Moran; Santarpia, Mariacarmela; M. A., Molina; L., Romero; F., Salazar; J. L., Ramirez; C., Queralt; J., Bertran Alamillo; I., Chaib; C., Costa; S., Benlloch; A., Vergnenegre; P., Garrido; C., Camps; M., Provencio; J. M., Sanchez; J., de Castro; B., Massuti | |
| Triple-negative breast cancer | 1-gen-2012 | R., Rosell; M. L., Botero; M., Gonzales Cao; M., Margeli; A., Barnadas; M. T., Cusido; R., Fabregas; C., Costa; A., Gimenéz Capitan; Santarpia, Mariacarmela; S., Benlloch | |
| EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung | 1-gen-2013 | Fabio, Conforti; Chiara, Catania; Francesca, Toffalorio; Matteo, Duca; Gianluca, Spitaleri; Massimo, Barberis; Cristina, Noberasco; Angelo, Delmonte; Santarpia, Mariacarmela; Chiara, Lazzari; Tommaso Martino De, Pas | |
| Cost-utility analysis of first-line treatment with erlotinib versus chemotherapy in EGFR-mutant advanced non-small-cell lung cancer (NSCLC): economic analysis of EURTAC trial (O16.03) | 1-gen-2013 | Vergnenegre, Alain; Rosell, Rafael; Massuti, Bartomeu; Do, Pascal; Corre, Romain; Felip, Enriqueta; Palmero, Ramon; Garcia Gomez, Ramon; Marinis, Filippo De; Santarpia, Mariacarmela; Wright, Elaine; Chouaid, Christos | |
| Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients. | 1-gen-2013 | Santarpia, Mariacarmela; De Pas, T. M.; Altavilla, Giuseppe; Spaggiari, L.; Rosell, R. | |
| Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets | 1-gen-2014 | F. Toffalorio;G. Spitaleri;C. Catania;L. Dal Zotto;C. Noberasco;A. Delmonte;M. Santarpia;F. Vecchio;V. Brunelli;C. Rampinelli;M. Barberis;C. Fumagalli;M. Zucchetti;M. Zangarini;T. Diena;R. Danesi;F. de Braud;T. De Pas | |
| Targeting ALK in patients with advanced Non Small Cell Lung Cancer: Biology, diagnostic and therapeutic options | 1-gen-2014 | Chiara Lazzari;Gianluca Spitaleri;Chiara Catania;Massimo Barberis;Cristina Noberasco;Mariacarmela Santarpia;Angelo Delmonte;Francesca Toffalorio;Fabio Conforti;Tommaso Martino De Pas | |
| Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 | 1-gen-2015 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ien6le, Valen6na; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebas6ano Pollina; Scondo_o, Salvatore; Cananzi, Pasquale; Caputi Achille, Patrizio; Trifiro', Gianluca | |
| Other targeted drugs in melanoma | 1-gen-2015 | González Cao, María; Rodón, Jordi; Karachaliou, Niki; Sánchez, Jesús; Santarpia, Mariacarmela; Viteri, Santiago; Pilotto, Sara; Teixidó, Cristina; Riso, Aldo; Rosell, Rafael | |
| Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints | 1-gen-2015 | Karachaliou, Niki; Cao, Maria Gonzalez; Teixidó, Cristina; Viteri, Santiago; Morales Espinosa, Daniela; Santarpia, Mariacarmela; Rosell, Rafael | |
| How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 | 1-gen-2015 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Bolcato, Jenny; Chinellato, Alessandro; Pirolo, Roberta; Tari, Daniele Ugo; Troncone, Chiara; Fontana, Andrea; Ientile, Valentina; Gini, Rosa; Santoro, Domenico; Santarpia, Mariacarmela; Genazzani, Armando; Uomo, Ilaria; Pastorello, Maurizio; Addario, Walter Sebastiano Pollina; Scondotto, Salvatore; Cananzi, Pasquale; Caputi, Achille Patrizio; Trifirò, Gianluca | |
| Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: Understanding transforming growth factor-beta role | 1-gen-2015 | Santarpia, Mariacarmela; González Cao, María; Viteri, Santiago; Karachaliou, Niki; Altavilla, Giuseppe; Rosell, Rafael | |
| Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer | 1-gen-2015 | Santarpia, Mariacarmela; Gil, Nuno; Rosell, Rafael | |
| Polycythemia vera and essential thrombocytemia treated with IFN-ALPHA2a: Evidence of a significant clinical activity and molecular response. | 1-gen-2015 | Altavilla, Giuseppe; Arrigo, C; Santarpia, Mariacarmela; Garipoli, Claudia; Pitini, V. (Pitini | |
| Advances in immunotherapy for treatment of lung cancer | 1-gen-2015 | Bustamante Alvarez, Jean G; González Cao, María; Karachaliou, Niki; Santarpia, Mariacarmela; Viteri, Santiago; Teixidó, Cristina; Rosell, Rafael | |
| Melanoma: oncogenic drivers and the immune system | 1-gen-2015 | Karachaliou, Niki; Pilotto, Sara; Teixidó, Cristina; Viteri, Santiago; González Cao, María; Riso, Aldo; Morales Espinosa, Daniela; Molina, Miguel Angel; Chaib, Imane; Santarpia, Mariacarmela; Richardet, Eduardo; Bria, Emilio; Rosell, Rafael | |
| BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer | 1-gen-2015 | Karachaliou, Niki; Codony Servat, Jordi; Teixidó, Cristina; Pilotto, Sara; Drozdowskyj, Ana; Codony Servat, Carles; Giménez Capitán, Ana; Molina Vila, Miguel Angel; Bertrán Alamillo, Jordi; Gervais, Radj; Massuti, Bartomeu; Morán, Teresa; Majem, Margarita; Felip, Enriqueta; Carcereny, Enric; García Campelo, Rosario; Viteri, Santiago; González Cao, María; Morales Espinosa, Daniela; Verlicchi, Alberto; Crisetti, Elisabetta; Chaib, Imane; Santarpia, Mariacarmela; Luis Ramírez, José; Bosch Barrera, Joaquim; Felipe Cardona, Andrés; De Marinis, Filippo; López Vivanco, Guillermo; Miguel Sánchez, José; Vergnenegre, Alain; Sánchez Hernández, José Javier; Sperduti, Isabella; Bria, Emilio; Rosell, Rafael | |
| Tumor immune microenvironment characterization and response to anti-PD-1 therapy | 1-gen-2015 | Santarpia, Mariacarmela; Karachaliou, Niki | |
| Alectinib: A selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer | 1-gen-2015 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Rosell, Rafael | |
| Personalized treatment of early-stage non-small-cell lung cancer: The challenging role of EGFR inhibitors | 1-gen-2015 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Pitini, Vincenzo; Rosell, Rafael |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile